Source:http://linkedlifedata.com/resource/pubmed/id/12023378
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2002-5-22
|
pubmed:abstractText |
IL-12p40 is required for the maintenance of resistance during Leishmania major infection. In this study, we addressed how IL-12 mediates this function. First, we demonstrated that both subunits of IL-12, p40 and p35, were required for continued resistance to L. major. Second, using IL-12, IL-4 doubly deficient mice, we investigated the possibility that IL-12 inhibits IL-4-induced outgrowth of Th2 cells that might compete with Th1 cells. We found that even in the absence of a Th2 response, IL-12 was still required to maintain resistance. Next, using adoptive transfer of Thy-1 disparate CD4(+) T cells from L. major-healed mice, we were able to show that the loss of a protective response in L. major-infected IL-12-deficient mice is linked with the loss of Th1 cells. In contrast, there was an equal recovery of CD4(+) Th1 cells from wild-type and IL-12-deficient mice when transferred into mice that were not challenged with L. major. The ability of Th1 cells to survive regardless of IL-12 levels in the absence of Ag stimulation was confirmed by adoptive transfer studies of CD4(+) Th1 cells from DO11.10 TCR transgenic mice. Taken together, these results indicate that, rather than modulating Th2 responses or optimizing IFN-gamma production, the critical role for IL-12 in maintaining cell-mediated immunity may be to prevent the loss of Th1 cells during a challenge infection.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
168
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5771-7
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12023378-Animals,
pubmed-meshheading:12023378-Female,
pubmed-meshheading:12023378-Immunity, Cellular,
pubmed-meshheading:12023378-Interleukin-12,
pubmed-meshheading:12023378-Interleukin-12 Subunit p35,
pubmed-meshheading:12023378-Interleukin-12 Subunit p40,
pubmed-meshheading:12023378-Leishmania major,
pubmed-meshheading:12023378-Leishmaniasis, Cutaneous,
pubmed-meshheading:12023378-Mice,
pubmed-meshheading:12023378-Mice, Inbred BALB C,
pubmed-meshheading:12023378-Mice, Inbred C57BL,
pubmed-meshheading:12023378-Protein Subunits,
pubmed-meshheading:12023378-Th1 Cells,
pubmed-meshheading:12023378-Th2 Cells
|
pubmed:year |
2002
|
pubmed:articleTitle |
The role of IL-12 in maintaining resistance to Leishmania major.
|
pubmed:affiliation |
Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104. Department of Environmental Sciences, Swiss Federal Institute of Technology, Zurich, Switzerland.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|